Polat Olgun

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Current oncology (Toronto, Ont.)

Current medical research and opinion

Balkan medical journal

European journal of breast health

This page only lists publications with an associated author ORCID identifier.

Publications

Polat Olgun, Omer Diker
Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current oncology (Toronto, Ont.) 30 (12) (2023)
Polat Olgun, Omer Diker
Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors. Current medical research and opinion 39 (3) (2023)
Polat Olgun, Omer Diker
Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors. Current medical research and opinion (2023)
Polat Olgun, Omer Diker
Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current oncology (Toronto, Ont.) 30 (12) (2023)
Polat Olgun, Omer Diker
Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current oncology (Toronto, Ont.) 30 (12) (2023)
Polat Olgun, Omer Diker
Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors. Current medical research and opinion 39 (3) (2023)
Polat Olgun, Omer Diker
Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors. Current medical research and opinion 39 (3) (2023)
Ibrahim Boga, Sebnem Ozemri Sag, Nilgun Duman, Sevda Yesim Ozdemir, Mahmut Çerkez Ergoren, Kubilay Dalcı, Cem Mujde, Cem Kaan Parsak, Cagla Rencuzogullari, Ozge Sonmezler, Orçun Yalav, Adem Alemdar, Lamiya Aliyeva, Özlem Bozkurt, Sibel Cetintas, Erdem Cubukcu, Adem Deligonul, Berkcan Dogan, Cemre Ornek Erguzeloglu, Türkkan Evrensel, Mustafa Şehsuvar Gökgöz, Kazım Şenol, Sahsine Tolunay, Esra Akyurek, Neslihan Basgoz, Nuriye Coskun, Bilge Dundar, Figen Öztürk, Duygu Taskin, Mercan Demirtas, Murat Cag, Omer Diker, Polat Olgun, Munis Dündar, Serdar Ceylaner, Sehime Gulsun Temel
A Multicenter Study of Genotype Variation/Demographic Patterns in 2475 Individuals Including 1444 Cases With Breast Cancer in Turkey. European journal of breast health 19 (3) (2023)
Polat Olgun, Omer Diker
Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current oncology (Toronto, Ont.) 30 (12) (2023)
Polat Olgun, Omer Diker
Sixth-Week Immune-Nutritional-Inflammatory Biomarkers: Can They Predict Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current oncology (Toronto, Ont.) 30 (12) (2023)
Atakan Demir, Nil Molinas Mandel, Semra Paydaş, Gökhan Demir, Ozlem Er, Nazım Serdar Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Saadettin Kılıçkap, Necdet Üskent, Nuri Karadurmus, Muhammet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez, Kadri Altundag, Seyda Gunduz, Meral Günaldı, Murat Sarı, Ismail Beypinar, Gül Başaran
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial Balkan medical journal 37 (2) (2020)